Mastek Limited has informed the Exchange about General Updates
MASTEK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mastek Limited has informed the stock exchanges that its Nomination and Remuneration Committee has approved the grant of 59,285 stock options to eligible employees under ESOP Scheme VII. The grant will take effect from August 1, 2025. The exercise price has been set at Rs. 5 per option, which equals the face (par) value of the company's equity shares. The options will vest over a 3-year period in tranches of 20% in Year 1, 30% in Year 2, and 50% in Year 3, with a maximum 7-year exercise window from each vesting date. The scheme is compliant with SEBI's Share Based Employee Benefits Regulations, 2021. If all options are exercised, a total of 59,285 equity shares of Rs. 5 face value each would be issued.
This is a routine ESOP grant and the potential dilution is very small relative to Mastek's overall share base, so it is unlikely to materially affect existing shareholders. The face-value pricing is favorable for employees but is a standard practice in many ESOP plans and does not indicate any unusual corporate action.